3rd FDA Panel Barely Favors BSX's Watchman

3rd FDA Panel Barely Favors BSX’s Watchman

3rd FDA panel vote barely favors Boston Scientific’s Watchman anti-stroke device Medtronic launches Verify incontinence device in the U.S FDA OKs Integra Lifesciences Puerto Rico plant; FDA approves Bard’s Lutonix DEB An FDA advisory panel offered a mixed view of Boston Scientific’s Watchman heart device earlier this month, concluding it is probably safe but not…